Investor Overview

Our Investor Information

Company Overview

Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity.

Copyright West LLC. Minimum 15 minutes delayed.

Annual Report
Press Releases
May 26, 2020
Rhythm Pharmaceuticals to Present Virtually at Upcoming Investor Conferences in June
May 13, 2020
Rhythm Pharmaceuticals Announces FDA Acceptance of New Drug Application for Setmelanotide for the Treatment of POMC and LEPR Deficiency Obesities
Upcoming Events
June 9, 2020 at 3:50 PM EDT
Goldman Sachs 41st Annual Global Healthcare Conference
June 2, 2020 at 3:00 PM EDT
Jefferies Virtual Global Healthcare Conference
Investor FAQs
More FAQs are coming soon.

Founded

Delaware, November 2008

Headquarters

222 Berkeley Street, 12th Floor
Boston, MA 02116
Phone: 857-264-4280

CUSIP number

76243J105

Transfer Agent

Computershare Trust Company, Inc.
250 Royall Street
Canton, MA 02021
www.computershare.com
US Phone: +1-800-962-4284
International Phone: + 1-781-575-3120